Advertisement
Correspondence| Volume 30, ISSUE 11, P1171, December 01, 1991

Calcium channel blocker nimodipine for primary degenerative dementia

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Berg L.
        • Storandt M.
        The longitudinal course of mild senile dementia of the Alzheimer type.
        in: Bergener M. Ermini M. Stahelin H.B. The 1988 Sandoz Lectures in Gerontology: Crossroads in Aging. Academic Press, London1983in: Bergener M. Ermini M. Stahelin H.B. The 1988 Sandoz Lectures in Gerontology: Crossroads in Aging. Academic Press, London1988
        • Katzman R.
        • Terry R.
        • DeTeresa R.
        • et al.
        Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques.
        Ann Neurol. 1988; 23: 138-144
        • McKhann G.
        • Drachman D.
        • Folstein M.
        • Katzman R.
        • Price D.
        • Stadlan E.M.
        Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
        Neurology. 1984; 34: 939-944
        • Tollefson G.D.
        Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia.
        Biol Psychiatry. 1990; 27: 1133-1142